Miñoza, Bonifacia .

HRN: 24-71-98  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2024
CEFTRIAXONE 1G (VIAL)
03/02/2024
03/07/2024
IV
2g
OD
UTI
Waiting Final Action 
03/04/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/04/2024
03/10/2024
IV
600mg
Q8
Carbuncle Lumbar Area
Waiting Final Action 
03/10/2024
CO-AMOXICLAV 625MG (TAB)
03/10/2024
03/15/2024
PO
625mg
Q8h
Carbuncle
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: